 |
인쇄하기
취소
|
Asia Pharmaceuticals Enters Gastric Ulcer Market
Asia Pharmaceuticals (Korean: A-Ju Pharm), via its strategic partnership with Japan’s Kotobuki Pharmaceuticals, enters the domestic gastric ulcer treatment market by launching Azuroxa Granule (Egualen Na 15mg).
Azuroxa Granule, developed by Kotobuki Pharmaceuticals, has Azuroxa, a new derivative of Azulene, as an active ingredient, and it is non-pH based and reinforces mucosal defensive func...
Azuroxa Granule, developed by Kotobuki Pharmaceuticals, has Azuroxa, a new derivative of Azulene, as an active ingredient, and it is non-pH based and reinforces mucosal defensive func...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.